Clinical Trials on 结肠肿瘤 in Peru
总计915个结果
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)招聘中III 期结肠癌 AJCC v8 | 结肠腺癌 | 微卫星稳定性结肠癌 | IIB 期结肠癌 AJCC v8 | IIC 期结肠癌 AJCC v8美国
-
Preventive Oncology International, Inc.Merck Sharp & Dohme LLC; Peru Instituto Nacional de Enfermadades Neoplasticas (INEN)完全的
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group完全的
-
NRG OncologyNational Cancer Institute (NCI)主动,不招人
-
National Cancer Institute (NCI)招聘中转移性结肠腺癌 | 转移性直肠腺癌 | III 期结肠癌 AJCC v8 | III 期直肠癌 AJCC v8 | IV 期结肠癌 AJCC v8 | IV 期直肠癌 AJCC v8 | 不可切除的结肠腺癌 | 不可切除的直肠腺癌美国, 波多黎各
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)主动,不招人复发性结肠癌 | 复发性直肠癌 | 直肠腺癌 | 结肠腺癌 | ERBB2基因扩增 | III 期结肠癌 AJCC v7 | III 期直肠癌 AJCC v7 | IIIA 期结肠癌 AJCC v7 | IIIA 期直肠癌 AJCC v7 | IIIB 期结肠癌 AJCC v7 | IIIB 期直肠癌 AJCC v7 | IIIC 期结肠癌 AJCC v7 | IIIC 期直肠癌 AJCC v7 | IV 期结肠癌 AJCC v7 | IV 期直肠癌 AJCC v7 | IVA 期结肠癌 AJCC v7 | IVA 期直肠癌 AJCC v7 | IVB 期结肠癌 AJCC v7 | IVB 期直肠癌 AJCC v7美国, 波多黎各
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; NCIC Clinical Trials Group; Cancer and Leukemia Group B; North...终止复发性结肠癌 | 复发性直肠癌 | IVA 期结肠癌 | IVA 期直肠癌 | IVB期结肠癌 | IVB期直肠癌美国
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
Duke UniversityFogarty International Center of the National Institute of Health完全的
-
NRG OncologyNational Cancer Institute (NCI); Natera, Inc.招聘中
-
Grupo de Estudios Clínicos Oncológicos PeruanoEuropean Organisation for Research and Treatment of Cancer - EORTC未知
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)主动,不招人III 期结肠癌 AJCC v8 | III 期直肠癌 AJCC v8 | IIIA 期结肠癌 AJCC v8 | IIIA 期直肠癌 AJCC v8 | IIIB 期结肠癌 AJCC v8 | IIIB 期直肠癌 AJCC v8 | IIIC 期结肠癌 AJCC v8 | IIIC 期直肠癌 AJCC v8 | IIA 期直肠癌 AJCC v8 | IIB 期直肠癌 AJCC v8 | II 期直肠癌 AJCC v8 | IIC 期直肠癌 AJCC v8 | I 期直肠癌 AJCC v8 | IIA 期结肠癌 AJCC v8 | IIB 期结肠癌 AJCC v8 | IIC 期结肠癌 AJCC v8 | I 期结肠癌 AJCC v8 | II 期结肠癌 AJCC v8美国
-
National Cancer Institute (NCI)主动,不招人林奇综合症 | 结肠黏液腺癌 | 结肠印戒细胞腺癌 | IIA 期结肠癌 AJCC v7 | IIB 期结肠癌 AJCC v7 | IIC 期结肠癌 AJCC v7美国, 加拿大, 波多黎各, 秘鲁, 南非
-
Eske Corporation S.A.C终止
-
The Cleveland ClinicNational Cancer Institute (NCI); Albert Einstein College of Medicine; University of Southern California 和其他合作者完全的
-
Duke UniversityUnited States Agency for International Development (USAID); Universidad Peruana Cayetano Heredia完全的
-
Abbott完全的肾功能不全,慢性 | 血液透析 | 继发性甲状旁腺功能亢进症 | 高钙血症 | 甲状旁腺激素秘鲁
-
Latin American Cooperative Onco-Haematology Group...未知
-
National Cancer Institute (NCI)主动,不招人林奇综合症 | III 期结肠癌 AJCC v8 | 结肠腺癌 | DNA修复障碍美国, 波多黎各, 德国
-
Universidad Peruana Cayetano HerediaFogarty International Center of the National Institute of Health完全的
-
Robert Roessle KlinikFederation Francophone de Cancerologie Digestive; European Organisation for Research and Treatment... 和其他合作者完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)主动,不招人
-
M.D. Anderson Cancer CenterBreast Cancer Research Foundation完全的
-
National Institute of Allergy and Infectious Diseases...完全的
-
NSABP Foundation IncNational Cancer Institute (NCI)终止
-
Al-Azhar UniversityHelwan University; National Liver Institute, Egypt完全的
-
Hoosier Cancer Research NetworkUnited States Department of Defense; Indiana University School of Medicine; Walther Cancer Institute终止
-
GlaxoSmithKline完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的大肠癌 | 转移癌美国, 澳大利亚, 秘鲁, 波多黎各
-
Latin American Cooperative Oncology Group主动,不招人
-
SanofiTaiho Pharmaceutical Co., Ltd.终止肿瘤转移 | 胰腺肿瘤美国, 法国, 加拿大, 巴西, 罗马尼亚, 瑞典, 突尼斯, 奥地利, 丹麦, 匈牙利, 秘鲁, 南非, 希腊, 哥斯达黎加, 以色列, 危地马拉, 巴拿马
-
Bristol-Myers Squibb完全的
-
International Atomic Energy AgencyInternational Network for Cancer Treatment and Research未知
-
Latin American Cooperative Oncology GroupGrupo de Estudios Clínicos Oncológicos Peruano完全的
-
Grupo Espanol de Investigacion en Sarcomas招聘中
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)完全的卡波氏肉瘤 | HIV-1 感染秘鲁, 肯尼亚, 马拉维, 巴西, 南非, 乌干达
-
International Agency for Research on Cancer主动,不招人